Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial
Status:
Completed
Trial end date:
2020-05-19
Target enrollment:
Participant gender:
Summary
In this study the investigators want to find out more about the addition of the antibiotic,
doxycycline, to standard anti-amyloid therapy in people with amyloidosis. The investigators
want to find out whether doxycycline improves the response to standard anti-amyloid therapy
and whether it causes any problems (side effects).